NPI: 1447206321 · ROSEVILLE, CA 95661 · Community Health Clinic/Center · NPI assigned 05/25/2006
Authorized official MOTSIFF, TOM controls 20+ related entities in our dataset. Read more
| Authorized Official | MOTSIFF, TOM (CFO) |
| NPI Enumeration Date | 05/25/2006 |
Other providers sharing the same authorized official: MOTSIFF, TOM
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 21,515 | $1.11M |
| 2019 | 14,767 | $610K |
| 2020 | 9,222 | $394K |
| 2021 | 14,550 | $720K |
| 2022 | 10,478 | $493K |
| 2023 | 15,570 | $874K |
| 2024 | 20,039 | $1.02M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7,015 | 6,809 | $682K |
| J3490 | Unclassified drugs | 15,682 | 12,891 | $571K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 536 | 527 | $498K |
| S4993 | Contraceptive pills for birth control | 4,316 | 4,237 | $484K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 1,020 | 1,008 | $429K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,208 | 2,173 | $361K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2,409 | 2,398 | $324K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,285 | 1,282 | $284K |
| 58300 | 1,537 | 775 | $162K | |
| 87806 | 7,029 | 6,030 | $153K | |
| 11981 | 526 | 518 | $124K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 156 | 156 | $118K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 5,611 | 5,336 | $110K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 333 | 332 | $97K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,627 | 1,588 | $91K |
| 99201 | 998 | 985 | $88K | |
| A4267 | Contraceptive supply, condom, male, each | 7,015 | 6,891 | $63K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2,747 | 2,733 | $63K |
| S0190 | Mifepristone, oral, 200 mg | 982 | 964 | $48K |
| J7304 | Contraceptive supply, hormone containing patch, each | 56 | 55 | $45K |
| 99401 | 2,231 | 2,217 | $43K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4,144 | 4,118 | $37K |
| J7300 | Intrauterine copper contraceptive (paragard) | 51 | 51 | $37K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4,158 | 4,131 | $36K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 2,669 | 2,669 | $34K |
| 58301 | 1,018 | 520 | $31K | |
| 99402 | 858 | 853 | $27K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 741 | 711 | $27K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 83 | 82 | $24K |
| 81025 | 7,075 | 6,943 | $24K | |
| 11976 | 293 | 156 | $20K | |
| S5000 | Prescription drug, generic | 2,398 | 2,244 | $20K |
| 99000 | 5,039 | 4,935 | $14K | |
| 99403 | 292 | 291 | $13K | |
| 83986 | 4,738 | 4,082 | $13K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 3,535 | 3,446 | $12K |
| S0191 | Misoprostol, oral, 200 mcg | 1,064 | 1,017 | $3K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 668 | 596 | $2K |
| 85018 | 623 | 599 | $2K | |
| 11982 | 30 | 14 | $2K | |
| 81002 | 926 | 903 | $2K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 124 | 123 | $1K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 67 | 38 | $505.85 |
| J4390 | 23 | 12 | $320.75 | |
| 86901 | 81 | 74 | $142.78 | |
| 0250 | 124 | 117 | $0.00 |